Skip to Content

Clicks Group Ltd CLS

Morningstar Rating
ZAC 30,637.00 +238.00 (0.78%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CLS is trading at a 728% premium.
Price
ZAR 304.73
Fair Value
ZAR 519.35
Uncertainty
High
1-Star Price
ZAR 513.68
5-Star Price
ZAR 825.55
Economic Moat
Lftpr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLS is a good fit for your portfolio.

Trading Information

Previous Close Price
ZAC 30,399.00
Day Range
ZAC 30,250.0030,764.00
52-Week Range
ZAC 23,263.0032,805.00
Bid/Ask
ZAC 30,086.00 / ZAC 30,810.00
Market Cap
ZAC 7.29 Tril
Volume/Avg
402,942 / 642,933

Key Statistics

Price/Earnings (Normalized)
27.54
Price/Sales
1.69
Dividend Yield (Trailing)
2.23%
Dividend Yield (Forward)
2.23%
Total Yield
4.45%

Company Profile

Clicks Group Ltd operates pharmaceutical health and beauty retail stores. The company primarily operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company targets middle- to upper-income consumers. Clicks' business strategy focuses on consistent product sourcing, product development, and measured store expansion. The company has a portfolio of retail franchise brands including The Body Shop, GNC, and claire's. Clicks uses United Pharmaceutical Distributors' capabilities for the groups' integrated channel to the healthcare market.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Mid Growth
Total Number of Employees
18,741

Comparables

Valuation

Metric
CLS
PMR
DCP
Price/Earnings (Normalized)
27.5431.90
Price/Book Value
13.826.90
Price/Sales
1.690.84
Price/Cash Flow
16.6814.51
Price/Earnings
CLS
PMR
DCP

Financial Strength

Metric
CLS
PMR
DCP
Quick Ratio
0.310.40
Current Ratio
1.031.18
Interest Coverage
13.373.92
Quick Ratio
CLS
PMR
DCP

Profitability

Metric
CLS
PMR
DCP
Return on Assets (Normalized)
14.51%4.77%
Return on Equity (Normalized)
47.21%18.96%
Return on Invested Capital (Normalized)
31.07%11.75%
Return on Assets
CLS
PMR
DCP
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncBgblxtwdYgw$15.6 Bil
RADLY
Raia Drogasil SA ADRVgbbcln$8.8 Bil
ALBHF
Alibaba Health Information Technology LtdCkyhyl$6.6 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRBmcrmz$6.6 Bil
CLCGY
Clicks Group Ltd ADRMmbtcd$3.9 Bil
SDGCF
Sundrug Co LtdYgjy$3.2 Bil
SGIPF
Sugi Holdings Co LtdNxj$2.8 Bil
SHPPF
Redcare Pharmacy NVJmxzl$2.4 Bil
SAEYY
Redcare Pharmacy NV ADRTdtlv$2.4 Bil
ZRSEF
DocMorris AGXshf$1.0 Bil

Sponsor Center